Solution Spotlight: Axtria HIQ
Axtria HIQ is an agentic analytics product built specifically for pharmaceutical headquarters teams.
Newsletters and Deep Dive digital magazine
Axtria HIQ is an agentic analytics product built specifically for pharmaceutical headquarters teams.
Digital health firm Everlywell is rolling out a Clairity AI, which can assess the risk of developing breast cancer from a mammogram, across the US.
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Industry must build custom solutions that leverage a pharmaceutical business’ unique assets – including its people.
An AI system can be cheap to buy and expensive to stop.
Editor's Picks
Newsletters and Deep Dive
digital magazine